Open Label, 12-Week Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate Dry Powder 400 Mcg Once-Daily in Persistent Mild-Moderate Asthmatic Patients at Least 12 Years Old.
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Mometasone (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms APEGO
- Sponsors Schering-Plough
- 19 Jul 2011 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 21 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 21 Aug 2009 Planned end date changed from 1 Mar 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.